Tuesday, September 15, 2026

Couldn’t Recognize Mariah Carey: Olympic Broadcast Chief Resigns

The broadcasting head responsible for multiple errors during the 2026 Milan-Cortina Winter Olympics opening ceremony has resigned.

US to Expand Tariffs on Steel and Auto Parts, Increasing Pressure on Korean Manufacturers

Trump's administration seeks input on expanding tariffs on steel, aluminum, and auto parts, impacting U.S. manufacturers and Korean suppliers.

Unlocking Alzheimer’s: The Surprising Role of Tau Protein in Cell Division Revealed

POSTECH researchers reveal tau protein's new role in DNA interaction, impacting Alzheimer's, infertility, and congenital disorders.

Tag: development

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

HLB Group’s New Cancer Drug Lirapegrafinib: What to Expect from FDA Approval on September 25?

HLB Group's drug development business is set to achieve key clinical and approval milestones in the second half of this year.

Revolutionizing Obesity Treatment: Hanmi Pharmaceutical’s Digital Fusion Drug EPPE Launching in 2026

Hanmi Pharmaceutical is developing digital therapeutics by combining obesity treatment 'Efe' with digital technology.

Revolutionary Cancer Drug Penitrium Shows Promise in Restoring Chemotherapy Effectiveness

Pennitrium Bioscience has confirmed the potential of a new drug candidate to enhance the effectiveness of existing cancer treatments.

FDA Designates BAL0891 as Rare Drug for Acute Myeloid Leukemia: What This Means for Cancer Treatment in Asia

Shinlajen's cancer drug candidate 'BAL0891' receives rare disease designation for acute myeloid leukemia from the FDA.

KIO-301: The Innovative Treatment for Retinitis Pigmentosa – What You Need to Know

Chong Kun Dang partners with Kiora Pharmaceuticals to develop and commercialize a new retinal disease treatment in South Korea.

“Preparing for the Next Pandemic After COVID-19”…South Korea Accelerates Development of Homegrown mRNA Vaccines

The South Korean government is accelerating domestic mRNA vaccine development to secure an independent vaccine technology platform capable of responding rapidly to future pandemics.

BMI2012: South Korea’s Next-Gen mRNA COVID-19 Vaccine Set for Clinical Trials

A consortium has received approval for the clinical trial of an mRNA-based COVID-19 variant vaccine, BMI2012.

Celltrion’s Three ADC Drug Candidates All Receive FDA Fast Track Designation

Celltrion has secured U.S. FDA Fast Track designation for all three of its antibody-drug conjugate candidates, accelerating development of its emerging oncology drug pipeline.

Samsung Bioepis, Built on Biosimilars, Expands Growth Strategy Into Novel Drugs

Samsung Bioepis is pursuing a two-track growth strategy that combines global biosimilar expansion with next-generation novel drug development, including ADC therapies.

Kangstem Biotech CSO Professor Kang Kyung-sun Confirms Therapeutic Potential of Vascularized Artificial Liver

Kangstem Biotech’s CSO Professor Kang Kyung-sun developed a vascularized artificial liver that showed therapeutic effects in animal models, offering potential for future transplant alternatives.

Beyond Approval to Insurance Coverage: Medical AI Companies Turn to Real-World Evidence to Drive Adoption

The focus of the medical AI industry is shifting from technology development to integration in healthcare settings.

How the SIALAP System Revolutionizes Preclinical Trials for Drug-Resistant Epilepsy

Researchers developed an objective framework for matching animal models to specific types of drug-resistant epilepsy, potentially improving the accuracy of preclinical drug development.

FDA Adjusts Drug Review Fees: Higher for New Drugs, Lower for Generics

The FDA’s 2027 fee changes lower review costs for new drugs and biosimilars while raising fees for generics and medical devices, with the impact varying by company.

PenetriumBioScience Files U.S. FDA IND for Phase 2a Trial in Advanced Solid Tumors

Penitrium Bioscience enters Phase 2a clinical trials in the U.S. for its cancer drug candidate 'Penitrium.'

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.